Glenmark Pharmaceuticals Share Price
02 Sep, 2026 3:52 PM (IST)
Glenmark Pharmaceuticals Performance
- Today's Low
- ₹2,420
- Today's High
- ₹2,477
- 52 Week Low
- ₹1,793
- 52 Week High
- ₹2,538
- Open Price₹2,455
- Previous Close₹2,470
- Volume529,948
- 50 DMA₹2,309.00
- 100 DMA₹2,255.70
- 200 DMA₹2,156.60
Glenmark Pharmaceuticals Chart
Investment Returns
- Over 1 Month + 10.12%
- Over 3 Month + 11.76%
- Over 6 Month + 15.13%
- Over 1 Year + 27.67%
Smart Investing Starts Here Start SIP with Glenmark Pharmaceuticals for Steady Growth!
Glenmark Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 38.6
- PEG Ratio
- 0.3
- Market Cap Cr
- 69,427
- P/B Ratio
- 6.3
- Average True Range
- 60.2
- EPS
- 63.7
- Dividend Yield
- 0.3
- MACD Signal
- 60.3
- RSI
- 64.37
- MFI
- 55.45
Latest Stock News Updates
Glenmark Pharmaceuticals Inc., USA launches Calcium Gluconate Injection USP, 1,000 mg/10 mL (100 mg/mL), 5,000 mg/50 mL (100 mg/mL) Single-Dose Vials and 10,000 mg/100 mL (100 mg/mL) Pharmacy Bulk Package
- BSE India
- 1 week 5 days ago
The product will be distributed in the US by Glenmark Pharmaceuticals Inc., USA
- Business Line
- 1 week 6 days ago
Glenmark Pharmaceuticals receives U.S. FDA approval for Fluticasone Propionate Nasal Spray, 0.05 mg (50 mcg)/spray
- BSE India
- 1 week 6 days ago
Glenmark Pharmaceuticals Financials
Glenmark Pharmaceuticals Technicals
EMA & SMA
- Bearish Moving Average 2
- Bullish Moving Average 14
- 20 Day
- ₹2,377.10
- 50 Day
- ₹2,309.00
- 100 Day
- ₹2,255.70
- 200 Day
- ₹2,156.60
Resistance and Support
- R3 2,541.50
- R2 2,509.20
- R1 2,484.60
- S1 2,427.70
- S2 2,395.40
- S3 2,370.80
Glenmark Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Glenmark Pharmaceuticals F&O
About Glenmark Pharmaceuticals
Glenmark Pharmaceuticals is primarily engaged in the business of development, manufacturing and marketing of pharmaceutical products. The Company's research and development facilities are located at Mahape, Sinnar and Taloja and manufacturing facilities a View More- NSE Symbol
- GLENMARK
- BSE Symbol
- 532296
- ISIN
- INE935A01035
Similar Stocks to Glenmark Pharmaceuticals
Popular Stocks
Glenmark Pharmaceuticals FAQs
Glenmark Pharmaceuticals share price is ₹2,460 As on 03 September, 2026 | 04:03
The Market Cap of Glenmark Pharmaceuticals is ₹69427.3 Cr As on 03 September, 2026 | 04:03
The P/E ratio of Glenmark Pharmaceuticals is 38.6 As on 03 September, 2026 | 04:03
The PB ratio of Glenmark Pharmaceuticals is 6.3 As on 03 September, 2026 | 04:03
The 52 week High & Low of Glenmark Pharmaceuticals is ₹2537.6/₹1792.6 respectively As on 03 September, 2026 | 04:03
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.